Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.543EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.543NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.543NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.543NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.543NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.139EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.139NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.139NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.139NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.139NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
C.31EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.31NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
C.31NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
C.31NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.31NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.221EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.221NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.221NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.221NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.221NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.362EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.362NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.362NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.362NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.362NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.265EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.265NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.265NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.265NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.265NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.585EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.585NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.585NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.585NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.585NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.351EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.351NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.351NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.351NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.351NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.36.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.36.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.36.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.36.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.322ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.160.23ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.416ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.239ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used